RegenMD - ACT receives Chinese patent for human ES cell-derived RPE cells

RegenMD         ACT receives Chinese patent for human ES cell-derived RPE cells March 25, 2011 at 12:55 AM   Advanced Cell Technology, Inc. (ACT) a leader in the field of regenerative medicine, announced that China's State Intellectual Property Office (SIPO) has allowed the company's patent application to provide broad intellectual property protection in ... See all stories on this topic »         Hamilton Thorne Announces Closing of Debentures Offering March 24, 2011 at 4:26 PM   BEVERLY, MA and TORONTO--(Marketwire - March 24, 2011) - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems for the regenerative medicine, developmental biology, stem cell research and fertility markets, today announced ... See all stories on this topic »         NewYork-Presbyterian Hospital Establishes New Pediatric Rehabilitation ... March 24, 2011 at 1:15 PM   ... Baruch Professor and chair of the Department of Rehabilitation and Regenerative Medicine at Columbia University College of Physicians and Surgeons, and professor and chief of the Division of Rehabilitation Medicine at Weill Cornell Medical College. ... See all stories on this topic »         Papering over the Pay Problem at CIRM: When is a $400,000 Salary Not $400,000? March 24, 2011 at 9:25 AM         The Existential Importance of Life Extension March 24, 2011 at 3:28 AM   The field of life extension is broad and ranges from regenerative medicine to disease prevention by nutritional supplements and phytomedicine. Although the relevance of longevity and disease prevention to existential risks is less apparent than the ... See all stories on this topic »             This email was sent to agupta1213+termsc@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here